N-[5-(2,3,5-TRI-O-ACETYL-BETA-D-RIBOFURANOSYL)-1H,5H-IMIDAZO-[4,5-B]-PYRAZOLO-[3,4-E]-PYRIDIN-1-YL]-ACETAMIDE
Compound with spectra: 1 NMR
![N-[5-(2,3,5-TRI-O-ACETYL-BETA-D-RIBOFURANOSYL)-1H,5H-IMIDAZO-[4,5-B]-PYRAZOLO-[3,4-E]-PYRIDIN-1-YL]-ACETAMIDE](/api/compound/KJLT9X4X4X6.png?ph=true&h=300&w=458 "N-[5-(2,3,5-TRI-O-ACETYL-BETA-D-RIBOFURANOSYL)-1H,5H-IMIDAZO-[4,5-B]-PYRAZOLO-[3,4-E]-PYRIDIN-1-YL]-ACETAMIDE")
| SpectraBase Compound ID | KJLT9X4X4X6 |
|---|---|
| InChI | InChI=1S/C20H21N5O8/c1-9(26)24-8-21-13-5-15-14(23-19(13)24)6-22-25(15)20-18(32-12(4)29)17(31-11(3)28)16(33-20)7-30-10(2)27/h5-6,8,16-18,20H,7H2,1-4H3/t16-,17-,18-,20-/m1/s1 |
| InChIKey | UXBGVZQXCPAJBB-SOAMZJECSA-N |
| Mol Weight | 459.42 g/mol |
| Molecular Formula | C20H21N5O8 |
| Exact Mass | 459.139013 g/mol |
| Enantiomer InChIKey | UXBGVZQXCPAJBB-JPLJXNOCSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
N-[7-(2,3,5-TRI-O-ACETYL-BETA-D-RIBOFURANOSYL)-1H,7H-IMIDAZO-[4,5-B]-PYRAZOLO-[3,4-E]-PYRIDIN-1-YL]-ACETAMIDE
1-(2,3,4,5-TETRA-O-ACETYL-BETA-D-GLUCOPYRANOSYL)-1H-NAPHTHO-[2,3-D]-[1,2,3]-TRIAZOLE
6-Chloro-2-(N'-methyl-2'-pyrrolyl)-9.beta.-(2',3',5'-tri-O-acetyl)-D,ribo-furanosylpurine
5-(1-HYDROXY-1-CARBOMETHOXYTRIFLUOROETHYL)-1-(TETRA-O-ACETYL-BETA-D-GLUCOPYRANOSYL)INDOLE (DIASTEREOMER MIXTURE)]
2',3',4',6'-Tetra-O-acetylmarrubiaside
CIS-CLERODA-3,13(14)-DIEN-15,16-OLIDE-18-O-[BETA-D-GALACTOPYRANOSYL]-PERACETYLESTER
HOOKERIOSIDE NONAACETATE
HOOKERIOSIDE-OCTAACETATE
[(2R,3R,4S,5R,6R)-3,4,5-triacetoxy-6-(3-carbamoylindol-1-yl)tetrahydropyran-2-yl]methyl acetate
[6-2H]-A,B-Bisnor-3.beta.-[(methylmercurio)methyl]-5.beta.-cholestan-5-carbaldehyde
| Title | Journal or Book | Year |
|---|---|---|
| Synthesis of New Nebularine Analogues and Their Inhibitory Activity against Adenosine Deaminase | CHEMICAL & PHARMACEUTICAL BULLETIN | 2015 |